EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date

Alessandro Giammona, Bruno Giovanni Galuzzi, Elena Imperia, Clarissa Gervasoni, Sofia Remedia, Laura Restaneo, Martina Nespoli iD, Laura De Gara iD, Flaminia Tani, Michele Cicala iD, Michele Pier Luca Guarino, Danilo Porro und 4 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26010413 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Alessandro Giammona und 15 weiteren Autor:innen. Beteiligte Einrichtung: Istituto di Bioimmagini e Sistemi Biologici Complessi (IBSBC), National Research Council (CNR), Segrate, 20054 Milan, Italy. Hauptthemen laut MEDLINE: MicroRNAs, Gastrointestinal Diseases, Irritable Bowel Syndrome, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Biodiversity Future Center, National Recovery and Resilience Plan (NRRP), European Union–NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic gastrointestinal disorders such as inflammatory bowel diseases (IBDs) and irritable bowel syndrome (IBS) impose significant health burdens globally. IBDs, encompassing Crohn’s disease and ulcerative colitis, are multifactorial disorders characterized by chronic inflammation of the gastrointestinal tract. On the other hand, IBS is one of the principal gastrointestinal tract functional disorders and is characterized by abdominal pain and altered bowel habits. Although the precise etiopathogenesis of these disorders remains unclear, mounting evidence suggests that non-coding RNA molecules play crucial roles in regulating gene expression associated with inflammation, apoptosis, oxidative stress, and tissue permeability, thus influencing disease progression. miRNAs have emerged as possible reliable biomarkers, as they can be analyzed in the biological fluids of patients at a low cost. This review explores the roles of miRNAs in IBDs and IBS, focusing on their involvement in the control of disease hallmarks. By an extensive literature review and employing bioinformatics tools, we identified the miRNAs frequently studied concerning these diseases. Ultimately, specific miRNAs could be proposed as diagnostic biomarkers for IBDs and IBS. Their ability to be secreted into biofluids makes them promising candidates for non-invasive diagnostic tools. Therefore, understanding molecular mechanisms through the ways in which they regulate gastrointestinal inflammation and immune responses could provide new insights into the pathogenesis of IBDs and IBS and open avenues for miRNA-based therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsGastrointestinal DiseasesIrritable Bowel SyndromeInflammatory Bowel DiseasesHumansBiomarkersChronic DiseaseAnimalsGene Expression Regulation

Stichwörter der Autor:innen

apoptosiscolorectal cancerhallmarks of IBD/IBSinflammationinflammatory bowel diseasemicroRNAoxidative stress

Substanzen

MicroRNAsBiomarkers

Autor:innen und Institutionen

  • Istituto di Bioimmagini e Sistemi Biologici Complessi (IBSBC), National Research Council (CNR), Segrate, 20054 Milan, Italy.
  • National Biodiversity Future Center (NBFC), 90133 Palermo, Italy.
  • Department of Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, 00128 Rome, Italy.
  • Dipartimento di Scienze della Terra e del Mare (DISTEM), Università di Palermo, Via Archirafi, 22, 90123 Palermo, Italy.
  • Research Unit of Gastroenterology, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo 21, 00128 Rome, Italy.
  • Unit of Gastroenterology, Fondazione Policlinico Campus Bio-Medico di Roma, Via Alvaro del Portillo 200, 00128 Rome, Italy.

ORCID-Profile: Martina Nespoli, Laura De Gara, Michele Cicala, Antonio Cerasa

Förderung

  • National Biodiversity Future Center
  • National Recovery and Resilience Plan (NRRP)
  • European Union–NextGenerationEU
  • Italian Ministry of University and Research

Zitieren

APA

Giammona, A., Galuzzi, B. G., Imperia, E., Gervasoni, C., Remedia, S., Restaneo, L., Nespoli, M., De Gara, L., Tani, F., Cicala, M., Guarino, M. P. L., Porro, D., Cerasa, A., Lo Dico, A., Altomare, A., & Bertoli, G. (2025). Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010413

Vancouver

Giammona A, Galuzzi BG, Imperia E, Gervasoni C, Remedia S, Restaneo L, et al. Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26010413

BibTeX
@article{Giammona2025,
  author = {Giammona, Alessandro and Galuzzi, Bruno Giovanni and Imperia, Elena and Gervasoni, Clarissa and Remedia, Sofia and Restaneo, Laura and Nespoli, Martina and De Gara, Laura and Tani, Flaminia and Cicala, Michele and Guarino, Michele Pier Luca and Porro, Danilo and Cerasa, Antonio and Lo Dico, Alessia and Altomare, Annamaria and Bertoli, Gloria},
  title = {Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26010413}
}
Kostenlos starten →